tRNAs are synthesized as immature precursors, and on their way to functional maturity, extra nucleotides at their 5 0 ends are removed by an endonuclease called RNase P. All RNase P enzymes characterized so far are composed of an RNA plus one or more proteins, and tRNA 5 0 end maturation is considered a universal ribozyme-catalyzed process. Using a combinatorial purification/proteomics approach, we identified the components of human mitochondrial RNase P and reconstituted the enzymatic activity from three recombinant proteins. We thereby demonstrate that human mitochondrial RNase P is a protein enzyme that does not require a trans-acting RNA component for catalysis. Moreover, the mitochondrial enzyme turns out to be an unexpected type of patchwork enzyme, composed of a tRNA methyltransferase, a short-chain dehydrogenase/reductase-family member, and a protein of hitherto unknown functional and evolutionary origin, possibly representing the enzyme's metallonuclease moiety. Apparently, animal mitochondria lost the seemingly ubiquitous RNA world remnant after reinventing RNase P from preexisting components.
INTRODUCTION
tRNAs are synthesized as immature precursors. Extra nucleotides at their 5 0 termini are removed by an endonuclease called ribonuclease P (RNase P, EC 3.1.26.5; Robertson et al., 1972) . All RNase P enzymes that have been characterized in molecular detail so far are composed of an RNA plus one or more proteins (reviewed in Evans et al., 2006; Hartmann and Hartmann, 2003; Walker and Engelke, 2006; or Willkomm and Hartmann, 2007) . While RNase P protein moieties exhibit diversity not only in number but also in structural homology, RNase P RNAs from the different domains of life appear to have a similar core structure, suggesting their evolution from a common primordial RNA world progenitor. Twenty-five years ago, the RNA moiety of bacterial RNase P was shown to be the catalytic subunit of the enzyme, capable of catalyzing 5 0 leader removal from tRNA precursors even in the absence of the protein subunit at elevated Mg 2+ concentrations (Guerrier-Takada et al., 1983) . More recently, RNase P RNAs from archaea and eukarya were found capable of mediating cleavage in the absence of protein, too (Kikovska et al., 2007; Pannucci et al., 1999) . RNase P is therefore not only generally considered to be a ribonucleoprotein, but tRNA 5 0 end maturation in addition to ribosomal protein synthesis considered the only ribozyme-catalyzed cellular process universally persistent since the hypothetical prebiotic RNA world (Gesteland et al., 2006) . Notwithstanding this general view, studies on RNase P activities from the organelles of some eukarya are at odds with a general ribonucleoprotein nature of the enzyme. Human mitochondrial and spinach chloroplast RNase P were both reported to have a protein-like density, to be insensitive to micrococcal nuclease treatment, and, if sufficiently purified, to be devoid of putative RNase P RNAs (Rossmanith and Karwan, 1998a; Rossmanith et al., 1995; Thomas et al., 1995; Wang et al., 1988) ; similar findings were reported for trypanosomal mitochondrial RNase P (Salavati et al., 2001) . However, because none of the protein components of one of these enzymes had been identified, all evidence remained essentially indirect, and so the idea of an RNAfree, protein-only RNase P has always been met with considerable skepticism (reviewed in Walker and Engelke, 2006) .
To finally resolve the enigma of one of these controversial RNAfree RNase P enzymes we identified the components of human mitochondrial RNase P (mtRNase P), expressed the three identified proteins in E. coli, affinity-purified them to homogeneity, and reconstituted the enzymatic activity from the purified subunits. Thereby we demonstrate that in contrast to all hitherto characterized RNase P enzymes, human mtRNase P does not require a trans-acting RNA for catalysis but is composed of protein only.
RESULTS

Identification of Human Mitochondrial RNase P Candidate Proteins by Establishing a ''Partial Purification Overlap Proteome''
Initial attempts to purify human mtRNase P were reproducibly associated with a rapid loss of activity and accordingly poor recovery. In order to avoid this apparent obstacle for a conventional purification-to-homogeneity approach we designed a strategy based on partial purification only, using a minimal number of purification steps and requiring only moderate amounts of starting material. Outlined in brief, this strategy identifies the overlap proteome of different partially purified enzyme preparations by determining which proteins they have in common as a basis for the selection of candidate proteins. According to the underlying rationale, even if the composition of the individual preparations is still complex, the ''partial purification overlap proteome'' (PPOP) should contain only a limited number of proteins in addition to the components of mtRNase P, thereby making screening and verifying of candidates by reverse genetic methods a feasible task. Other combinatorial proteomics approaches have previously been successfully used to define awkward biochemical preparations, and the PPOP principle can be viewed as a reversal of the concept of subtractive proteomics (Andersen et al., 2003; Schirmer et al., 2003) .
To avoid the potential confusion of mtRNase P activity with that of nuclear RNase P (nRNase P), a minor but persistent contaminant of mitochondrial preparations (Rossmanith and Potuschak, 2001; Rossmanith et al., 1995) , we used the precursor of mitochondrial tRNA Tyr ((mt)pre-tRNA Tyr ) as a substrate for mtRNase P throughout all purification steps. Notably, (mt)pretRNA Tyr is not a substrate for nRNase P (Rossmanith et al., 1995) .
Mitochondria were isolated from HeLa cells and purified by density gradient centrifugation and digitonin treatment. Cleared detergent lysates or sonicates were subjected to chromatography on anion exchange, hydrophobic interaction, or chromatofocusing media ( Figure 1A ). Fractions containing mtRNase P activity were pooled and further purified by chromatography on heparin affinity matrix or by rate-zonal sedimentation in glycerol gradients. The five different two-step purification procedures ( Figure 1A ) increased the specific activity of the peak fraction of the second step between 5-and 30-fold ( Figure 1B ). In line with the rationale of our PPOP strategy the SDS polyacrylamide gel electrophoresis (SDS-PAGE) patterns of the five preparations were basically dissimilar ( Figure 1C ).
The proteome of each mtRNase P preparation was sizefractionated by SDS-PAGE ( Figure 1C ), gel slices subjected to in-gel tryptic digestion, and peptides identified by mass spectrometry. The entire proteome analysis of each preparation was independently performed on two different mass spectrometry platforms. Proteins identified by the two analyses were pooled, resulting in a total number of distinct proteins of between 166 and 362 per preparation ( Figure 1D and Tables S1-S7 available online). Overall, in the five partially purified mtRNase P preparations, 884 distinct proteins were identified (Tables S7 and S8) , none of which was a previously described RNase P protein or homologous to a previously described RNase P protein.
From these five proteome sets, the PPOP was compiled: 24 of the 884 proteins were identified in all five preparations (Table 1) , 29 in four, 81 in three, 164 in two of the five preparations, and 586 were unique to one of the sets (Tables S6-S9 ). All PPOP proteins were examined for their known or predicted biological function, biochemical pathway, catalytic role, and subcellular localization; information retrieved from various public databases was supplemented by domain/motif analyses and a prediction of mitochondrial targeting potential. Moreover, prospective mtRNase P candidate proteins were reasoned to score better in a ranking based on the number of peptides per protein in preparations with a more pronounced increase in relative specific activity (Figure 1 ; (B) Specific activity of the partially purified mtRNase P preparations relative to the starting material in each case. (C) mtRNase P preparations separated by SDS-PAGE and stained by Coomassie Brilliant Blue (gels shown were subsequently processed for ion-trap mass spectrometry). Preparations run in different gels, from left to right: molecular weight standards and mitochondrial extract (detergent lysate), 10% gel; Mono Q/glycerol gradient-purified mtRNase P, 8% gel; Mono Q/heparin sepharose-purified mtRNase P, 10% gel; phenyl sepharose/heparin sepharose-purified mtRNase P, 10% gel; Mono P/glycerol gradient-purified mtRNase P, 10% gel; Mono P/heparin sepharose-purified mtRNase P, 8% gel. Molecular weight standards comigrated in each gel and indicated by short bars are the same as in the leftmost gel; the migration front is indicated by the long bar. (D) Number of proteins identified in above indicated preparations (see also Table S7 ).
Tables 1 and S9); i.e., candidates were expected to have basically lower group numbers (better rank) in preparations based on, e.g., Mono P chromatofocusing than in the phenyl sepharose/heparin sepharose preparation. Assuming that mtRNase P might not have been sufficiently enriched in all five preparations to allow identification of its components, we extended the analysis to the proteins identified in four and three of five preparations (Tables S8 and S9) .
Based on these analyses three proteins fulfilled the following criteria: (1) they were found to be potentially involved in RNA Table S8 for a complete listing and Tables S1-S9 for further details not listed here). b Ranking based on the number of shared peptides per protein for each preparation and mass spectrometry analysis. Group number from ion-trap mass spectrometer and Spectrum Mill analysis listed first; group number from quadrupole time-of-flight (QTOF) mass spectrometer and Mascot/ EpiCenter analysis listed after the semicolon; -, not identified by one of the mass spectrometry platforms (depending on position).
metabolism (database annotation and/or specific domains/ motifs), (2) they were predicted to be mitochondrial, and (3) they showed a rank distribution in the five subproteomes roughly consistent with the relative specific activity of mtRNase P in the respective preparations. The three proteins selected for further testing were RNA (guanine-9-)methyltransferase domain containing 1 (RG9MTD1; UniProt Q7L0Y3), the uncharacterized protein C17orf42 (Q96QE5), and the uncharacterized protein KIAA0391 (Q8N5L5), the latter not identified in the two preparations based on Mono Q chromatography (Tables S8 and S9 ).
Overexpression of Candidate Genes in 293 Cells and Affinity Purification of mtRNase P Assuming that mtRNase P is a multisubunit enzyme, we decided to test the selected candidate-protein subunits by tagged overexpression in human cells to enable them to assemble with endogenous components. A fraction of mtRNase P should thereby become tagged and amenable to affinity purification. cDNAs of the three proteins were cloned in frame with C-terminal affinity tags, and 293 cell lines capable of inducible transgene expression were generated. Mitochondria were prepared from expression-induced cells and extracts assayed for mtRNase P activity or subjected to affinity purification. Overexpression of RG9MTD1 resulted in an increase in mtRNase P activity in crude mitochondrial extracts when compared to cells overexpressing C17orf42 or to control cells (Figures 2A and 2C , compare lanes 1 and 2 in each panel). Moreover, upon affinity purification only RG9MTD1, but not C17orf42, was associated with mtRNase P activity (Figures 2A and 2B) . Cloning of KIAA0391 lagged behind that of the other two cDNAs, and the generation of cell lines expressing KIAA0391 was stopped when the association of RG9MTD1 with mtRNase P was identified.
A protein of approximately 26 kDa copurified with RG9MTD1 ( Figure 2B , lanes 11 and 13). The apparent association was confirmed by overexpression of RG9MTD1 with a FLAG-instead of a 63 His-tag and subsequent anti-FLAG immunoprecipitation instead of immobilized metal affinity chromatography (IMAC) ( Figures 2C and 2D ). Mass spectrometry revealed the 26 kDa protein to be hydroxysteroid (17-b) dehydrogenase 10 (HSD17B10), in the literature more frequently referred to as 3-hydroxyacyl-CoA dehydrogenase type 2 (HADH2). In fact HSD17B10 was a constituent of the PPOP (Table 1) , but although its rank distribution in the five subproteomes was compatible with the relative specific activity of mtRNase P, we did not initially consider it as a mtRNase P protein candidate because of its attributed catalytic activities. However, in agreement with our data, an interaction of the Drosophila melanogaster homologs of RG9MTD1 and HSD17B10 was previously found in a two-hybrid screen of the fly proteome (Giot et al., 2003) . Thus, since both proteins were consistently associated with mtRNase P activity, we termed them mitochondrial RNase P protein (MRPP) 1 (RG9MTD1) and MRPP2 (HSD17B10).
Identification of a Third Protein Subunit by Functional
Reconstitution of mtRNase P from Recombinant MRPP1 and MRPP2 and Mitochondrial Fractions Recombinant MRPP1 and MRPP2, expressed in E. coli, did not show mtRNase P activity, neither alone nor when assayed in combination (see also below). Yet, when both proteins were added to mitochondrial extract, mtRNase P activity was stimulated several-fold ( Figure 3C , compare lanes 1 and 13), indicating that in vitro reconstitution of mtRNase P from bacterialexpressed recombinant MRPP1 and MRPP2 is possible, apparently requiring only one or more additional components. Size fractionation/reconstitution experiments suggested an additional protein component of approximately 60 kDa: mtRNase P activity could be reconstituted from recombinant MRPP1 and MRPP2 and protein(s) eluting from a gel slice of SDS-PAGE-fractionated mitochondrial extract in the 60 kDa range ( Figure 3A) ; notably, no RNA was found in this 60 kDa fraction (data not shown). The high protein density in this molecular weight range, however, precluded direct protein identification by mass spectrometry, necessitating further purification/subfractionation.
During affinity purification of MRPP1-tagged mtRNase P from human cells we observed an inverse correlation of mtRNase P activity and purity, but not quantity of MRPP1 and MRPP2: low-salt purifications were generally associated with good yields of activity but considerable impurities (data not shown), whereas high salt resulted in almost homogenous MRPP1 and MRPP2 but poor recovery of mtRNase P activity ( Figure 2 ). Thus we reasoned that the missing component associates in a salt-labile manner with the two other proteins. Mitochondrial extract from 293 cells overexpressing His-tagged MRPP1 was applied to an IMAC column at low salt, and the column developed with 50 mM steps of NaCl to elute proteins associated with the MRPP1/MRPP2 complex, which itself remained bound to the matrix ( Figure 3B ). While salt-wash fractions did not exhibit mtRNase P activity on their own, mtRNase P could be reconstituted by the addition of recombinant MRPP1 and MRPP2 to the 150 mM salt-wash fraction ( Figure 3C ). This fraction was thus subjected to SDS-PAGE, and gel slices split and subjected to elution/reconstitution as well as mass spectrometry. From the slice capable of reconstituting mtRNase P activity 17 proteins were identified (Table S10) , two of which were also present in the PPOP, and one, KIAA0391, that had already been considered a candidate but was not pursued any further after the identification of MRPP1.
Functional Reconstitution of mtRNase P from Three Recombinant, Affinity-Purified Proteins without RNA MRPP1, MRPP2, and KIAA0391 (designated hereafter as MRPP3) were expressed in E. coli and purified to apparent homogeneity by IMAC ( Figure 4A ). None of the three proteins alone, nor combinations of two of them, showed any pre-tRNA processing activity. However, a mixture of all three recombinant proteins reconstituted mtRNase P activity cleaving different (mt)pretRNAs in a manner identical to mitochondrial extract (Figures 4B and 4C) . Cleavage sites of recombinant mtRNase P were mapped to the tRNAs' 5 0 ends by high-resolution urea-PAGE ( Figures  4D and 4E ). Like native mtRNase P (Rossmanith et al., 1995) , recombinant mtRNase P generated tRNAs with 5 0 -phosphate ends ( Figures 4F-4I ) and required Mg 2+ for catalysis (data not shown).
Obviously, no RNA of human origin is required for the functional reconstitution of human mtRNase P; enzyme reconstitution from proteins produced in E. coli excludes other components of human origin but the proteins expressed. Yet, could minor contaminants from the expression host be involved in reconstituting mtRNase P? In particular, is an E. coli RNA involved in or responsible for catalysis? The fact that none of the three proteins alone showed any traceable mtRNase P activity appears to rule out any contamination of functional significance ( Figures 4B and 4C ). Still the possibility remained that a copurifying E. coli RNA acted in concert with all three proteins only. In fact, the purified proteins still contained low amounts of RNA ( Figure 4K , lane 4; 10 ng per mg protein). However, treatment with micrococcal nuclease completely removed any RNA without sacrificing mtRNase P activity ( Figures 4J and 4K) . Moreover, deliberate addition of either M1 RNA, the RNA component of E. coli RNase P, or E. coli total RNA both inhibited instead of stimulated mtRNase P activity ( Figures 4J and 4K ). M1 RNA concentrations above 20 nM, and E. coli total RNA above 2.5 ng/ml, became increasingly inhibitory under standard assay conditions, yet concentrations below did not affect the enzymatic activity, i.e., neither inhibited nor stimulated (full range tested: 0.1-100 nM M1 RNA, 0.05-50 ng/ml E. coli total RNA; data not shown). And though the mechanism of inhibition is not known, the lack of stimulation confirms that no RNA from the expression host was involved in reconstituting mtRNase P activity from the three recombinant proteins. In summary, all data are incompatible with the involvement of any kind of trans-acting RNA, human or bacterial, inferring that human mtRNase P is composed of three proteins but no RNA.
Accumulation of Mitochondrial tRNA Precursors and Loss of mtRNase P Activity after RNAi-Mediated Silencing of MRPP1, MRPP2, or MRPP3 Gene Expression To substantiate the inferred physiological role of MRPP1, MRPP2, and MRPP3 in mitochondrial tRNA 5 0 end maturation in vivo we subjected their expression to a transient knockdown by RNAi. The supposed deficiency in mtRNase P activity was reasoned to give rise to an increase in the cellular steady-state levels of (mt)pre-tRNAs. Two different siRNAs were used for each gene. All of them caused a decrease of the targeted mRNA ( Figures 5A-5C ) but no change in the steady-state levels of the other, nontargeted MRPP mRNAs (data not shown). With a delay of 2 to 6 days relative to the respective mRNA minima, (mt)pre-tRNA Val levels increased to temporarily peak at 6-to 60-fold above those of untreated cells ( Figures 5D-5F ); (mt)pre-tRNA Ile accumulated concurrently, but its accumulation was less pronounced (Figures 5G-5I) . Consistent with the transient nature of siRNA transfections, specific mRNA reduction and concomitant (mt)pre-tRNA accumulation reversed to normal within a few days. The variation of the relative mRNA and (mt)pretRNA levels of control siRNA-treated cells was less than 2-fold ( Figure 5 ) and thereby within the fluctuation range of untreated cell samples (data not shown). Extent and kinetics of (mt)pre-tRNA accumulation are not directly related to the RNAi-induced mRNA reduction but depend also on the initial cellular concentration, the stability, and the resynthesis rate of the respective protein. It is thus not surprising that the degree of (mt)pre-tRNA accumulation varied between the three MRPP genes and was not a direct function of the maximally achieved mRNA reduction; e.g., (mt)pre-tRNA Val increased almost 30-fold after MRPP1 silencing but only 6-fold in the case of MRPP3, although mRNA reduction of the latter was even slightly more pronounced. Likewise, the offset between mRNA minimum and (mt)pre-tRNA maximum was specific for the target gene. Consistently, the two different siRNAs used to silence the expression of a particular gene gave rise to the same kinetics of (mt)pre-tRNA accumulation. For a given target gene the extent of (mt)pre-tRNA accumulation nevertheless depended on the knockdown capacity of the respective siRNA. This was most obvious in the case of MRPP2, where the much stronger and more persistent knockdown effect of siRNA #2 caused a more than 60-fold increase of (mt)pre-tRNA Val , while the less potent siRNA #1 elicited only a 6-fold increase (Figure 5E) ; in both cases (mt)pre-tRNAs nevertheless peaked at day 9 after transfection. Since we had no means to determine the levels of the three proteins directly, we scaled up and prepared and assayed mtRNase P activity from siRNA-treated cells. Reductions in mtRNase P activity should roughly correlate with the extent of (mt)pre-tRNA accumulation, if the latter is due to the RNAi-mediated loss of a genuine component of mtRNase P. A potent siRNA and a point in time between mRNA minimum and (mt)pre-tRNA maximum were selected for each gene, reasoning that the greatest loss of mtRNase P activity would be delayed to mRNA reduction but precede the peak of (mt)pre-tRNA accumulation. While control siRNA transfections did not alter mtRNase P activity, siRNAs targeting any of the three MRPP genes caused a reduction in mtRNase P activity (Figure 6 ). Consistent with the lower (mt)pre-tRNA accumulation potency of MRPP3 siRNAs, more mtRNase P activity remained after MRPP3 knockdown than after those of the other two mtRNase P genes. In conclusion, RNAimediated knockdown of any of the three MRPPs caused a transient mtRNase P deficiency with the concomitant accumulation of (mt)pre-tRNAs. Thus all three proteins that are required and sufficient to reconstitute an enzymatic activity capable of specifically cleaving (mt)pre-tRNAs at their 5 0 end in vitro (without the need for any kind of trans-acting RNA) are also directly involved in (mt)pre-tRNA 5 0 end maturation in vivo.
DISCUSSION
Molecular identification of an RNase P devoid of RNA is without precedent so far. Since the first demonstration that the prototype E. coli enzyme contains an essential RNA moiety (Stark et al., 1978) , every RNase P characterized in molecular detail had been found to contain a structurally related RNA, too. Moreover, the recent demonstration that eukaryal nRNase P RNA is capable of mediating pre-tRNA cleavage in the absence of protein like its bacterial or archaeal counterparts (Kikovska et al., 2007) appeared to add further support to the prevailing view that the RNA-based catalytic mechanism of pre-tRNA 5 0 cleavage has been universally preserved during evolution.
An RNase P composed entirely of protein was actually first proposed 20 years ago (Wang et al., 1988) , but none of the components of this chloroplast enzyme have been identified since then. Now, the identification of the components of human mtRNase P, proposed to be purely proteinaceous 10 years ago (Rossmanith and Karwan, 1998a) , and the functional reconstitution of its enzymatic activity from recombinant proteins add proof to the idea of nonribozymal 5 0 pre-tRNA maturation and reveal how the seemingly universal RNA world remnant has been replaced in the animal mitochondrial lineage. Not surprisingly, none of the three mtRNase P proteins displays any apparent similarity to a known RNase P protein, including the yeast mitochondrial one (Dang and Martin, 1993) . Evidently, evolution built a new enzyme, and any remains of the ribozyme originally inherited from the a-proteobacterial ancestor were subsequently lost. However, animal mtRNase P was not built simply from components of a preexisting nucleolytic pathway but by combining components from different, essentially unrelated biochemical pathways. Yet, at least two of these components, MRPP1 and MRPP2, were apparently not recruited by gene duplication and subsequent functional transformation, but the new function rather seems to be an add-on to their preexisting role. Animal mtRNase P thereby appears like a patchwork composed of two proteins involved in other biochemical processes too and one protein of hitherto unknown functional and evolutionary origin.
The Components of Human mtRNase P MRPP1 (RG9MTD1) is one of three vertebrate homologs to yeast TRM10. Trm10p is a tRNA m 1 G methyltransferase responsible for modification at position 9 (Jackman et al., 2003) , a common modification of eukaryal tRNAs (Sprinzl and Vassilenko, 2005) . A TRM10 homolog is widely found in eukaryal and archaeal genomes, but not in eubacteria. Only metazoan genomes appear to encode two or three homologs, one of which is mitochondrial according to its conserved targeting sequence (J.H. and W.R., unpublished data; Pagliarini et al., 2008) . Notably, m 1 G 9 is frequently found in animal but not in yeast or plant mitochondrial tRNAs (Sprinzl and Vassilenko, 2005) , and preliminary evidence indeed suggests that MRPP1 functions in the m 1 G 9 methylation of human mitochondrial tRNAs (C. Nachbagauer, J.H., and W.R., unpublished data). The putative mitochondrial TRM10 homologs were reported to branch separately from those that group with yeast and plant in a phylogenetic reconstruction of the family's evolution (Jackman et al., 2003 ). Yet, the implied phylogenetic placement could well be the artifactual result of a duplication early in the branching of metazoans with a subsequently more rapid evolution of the mitochondrial lineage to cope with its newly acquired function as well as with the structural changes of animal mitochondrial tRNAs, instead of a selective retention of two lineages in animals and loss of (the mitochondrial) one in protists, fungi, and plants, as suggested by the authors. Such a scenario could also explain the apparently even earlier branching of the nematode homolog as a result of adaptation to the bizarre structure of nematode mitochondrial tRNAs (Wolstenholme et al., 1987 ). It appears reasonable to assume that MRPP1 contributes specific tRNA-binding capacity to mtRNase P. A G 9 methyltransferase as a putative specificity component, however, implies a mode of substrate recognition distinct from that of other known RNase P enzymes. The purine ring of residue 9 appears buried in the core of the tRNA structure and is involved in a triple interaction with base pair 1223 in the crystal structure of yeast tRNA Phe (Sussman and Kim, 1976) . tRNA core and hence neighborhood of position 9 are built by D domain, variable loop, and anticodon stem, which thereby represent plausible contact points for an m 1 G 9 methyltransferase. Consistently, alterations of these structural elements were previously observed to affect processing by mtRNase P but not by nRNase P (Rossmanith et al., 1995; Rossmanith, 1997; Rossmanith and Karwan, 1998b) . Since G 9 appears inaccessible for methylation enzymes in the core of the L-shaped tRNA structure, binding (and methylation) by MRPP1 and consequently processing by mtRNase P might be associated with a transient reorganization of the tRNA structure. Such disruption of tertiary interactions and remolding of tRNA was in fact reported for a G 15 transglycosylase (Ishitani et al., 2003) .
While MRPP1 appears to contribute tRNA-binding capacity to mtRNase P, the role of its binding partner MRPP2 is less obvious. MRPP2 (HSD17B10) is a member of the ubiquitous short-chain dehydrogenase/reductase (SDR) family (Jö rnvall et al., 1995) . A plethora of names refers to the wide variety of fatty acid, steroid, and alcohol substrates oxidized by the enzyme in vitro (common acronyms: HSD17B10, HADH2, ABAD, SCHAD, MHBD), though its actual biological role is unclear (reviewed in Yang et al., 2005) . Mutations in its gene on Xp11.2 have been linked to 2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency, involving the protein in isoleucine metabolism and neurodegeneration (Ofman et al., 2003) . Recently, a reduction of its expression has (F) Characterization of the 5 0 nucleotide of (mt)tRNA Tyr as processed by recombinant mtRNase P. The tRNA precursor, labeled with [a 32 P]GTP, was incubated with recombinant mtRNase P, and the cleavage product was isolated and subjected to complete alkaline hydrolysis; nucleoside phosphates were resolved by two-dimensional thin layer chromatography (TLC). Guanosine 3 0 ,5 0 -bisphosphate (pGp) spot from the tRNA's 5 0 end indicated.
(G) Phosphatase sensitivity of the 5 0 nucleotide of (mt)tRNA Tyr as processed by recombinant mtRNase P. The tRNA precursor, labeled with [a 32 P]GTP, was incubated with recombinant mtRNase P; the cleavage product was isolated, treated with alkaline phosphatase, and subsequently subjected to complete alkaline hydrolysis; nucleoside phosphates were resolved by two-dimensional TLC. pGp spot visible in (F) was removed by phosphatase pretreatment of the mtRNase P cleavage product.
(H) Characterization of the 5 0 nucleotide of (mt)tRNA Ile as processed by recombinant mtRNase P. Same procedure as described for (F); Adenosine 3 0 ,5 0 -bisphosphate (pAp) spot from the tRNA's 5 0 end indicated.
(I) Phosphatase sensitivity of the 5 0 nucleotide of (mt)tRNA Ile as processed by recombinant mtRNase P. Same procedure as described for (G); pAp spot visible in (H) was removed by phosphatase pretreatment of the mtRNase P cleavage product.
(J) mtRNase P activity of reconstituted mtRNase P treated with micrococcal nuclease (lane 2) and/or supplemented with 12.5 ng/ml (100 nM) M1 RNA (lanes 3 and 4) or supplemented with 10 or 50 ng/ml E. coli total RNA (lanes 5 and 6); substrate, 2 nM (mt)pre-tRNA Ile . (K) RNA isolated from reconstituted, micrococcal nuclease-treated or RNA-supplemented mtRNase P preparations. Six percent urea-PAGE stained with SYBR Green I; full gel range from loading slots to the migration front at 35 nucleotides shown; representative RNA species indicated for approximate sizing. Lanes 1 to 3, indicated amounts of M1 RNA, each carried through the same RNA isolation procedure (it was derived from this part of the experiment that the procedure would have allowed the detection of less than 10 ng of a certain RNA species); lanes 4 and 5, RNA isolated from 25 mg of recombinant mtRNase P, the 100-fold amount of reconstituted, micrococcal nuclease-treated mtRNase P employed in (J); lanes 6 to 9, RNA isolated from 375 ng of recombinant mtRNase P, the 1.5-fold amount of reconstituted, micrococcal nuclease-treated or RNA-supplemented mtRNase P employed in (J).
moreover been linked to a form of X-linked mental retardation (Lenski et al., 2007) . MRPP2 owes two further designations (ERAB, ABAD) to its amyloid-b-binding capacity, connecting the protein to Alzheimer's disease (Chen and Yan, 2007) . It is intriguing to speculate that MRPP2 0 s role in mitochondrial tRNA processing actually contributes to its associated pathologies, in particular to amyloid-b-induced mitochondrial dysfunction in Alzheimer's disease (Chen and Yan, 2007) . The structure of MRPP2 is remarkably conserved throughout the animal kingdom, and MRPP2 may contribute to tRNA binding of the MRPP1/MRPP2 complex via its NAD + -binding domain; this domain, also known as Rossmann fold, has in fact been proposed to be a common RNA-binding motif (Hentze, 1994; Nagy et al., 2000) . tRNA binding could thus well be attributed to the MRPP1/ MRPP2 complex. But where does the required hydrolytic activity come from? Database entries of MRPP3 (KIAA0391) show no kind of functional annotation. Like MRPP1, MRPP3 has a typical matrix targeting sequence routing a GFP-tagged variant of MRPP3 to mitochondria (J.H., E.L., and W.R., unpublished (E) Relative quantity of (mt)pre-tRNA Val after RNAi-mediated silencing of MRPP2 gene expression.
(F) Relative quantity of (mt)pre-tRNA Val after RNAi-mediated silencing of MRPP3 gene expression.
(G) Relative quantity of (mt)pre-tRNA Ile after RNAi-mediated silencing of MRPP1 gene expression.
(H) Relative quantity of (mt)pre-tRNA Ile after RNAi-mediated silencing of MRPP2 gene expression.
(I) Relative quantity of (mt)pre-tRNA Ile after RNAi-mediated silencing of MRPP3 gene expression. data). Pfam domain analysis revealed two degenerate in-tandem pentatricopeptide repeats (PPR): amino acids 211-244 and 245-279. A PPR is a degenerate 35 amino acid motif occurring in tandem arrays of 2-26 per protein (Lurin et al., 2004) . It was identified as defining a huge gene family in Arabidopsis thaliana comprised of 450 members, most of which are predicted to be targeted to mitochondria or chloroplasts. In nonplant eukarya PPR proteins are more rare, and they are essentially absent from bacterial genomes. PPRs are suggested to be RNA-binding motifs, though little is known about the actual molecular interactions involved. Apart from the two PPRs no established structural motif could be identified in MRPP3. Multiple sequence alignment of animal MRPP3 homologs nevertheless showed several conserved sequence blocks in the C-terminal part of the protein, indicating their potential functional significance ( Figure S1A ); C-terminal homology appears to actually define a new gene family found in animals, plants, and kinetoplastid protozoa ( Figure S1B ). While animal genomes appear to encode only one putative MRPP3 homolog, the family appears expanded to three genes in flowering plants. Two putative homologs were also identified in trypanosomes. In many MRPP3 homologs, two in-tandem PPR motifs could be identified in apparently similar C-terminal spacing ( Figure S1 ; see figure legend for further comments). In the largest block of high similarity between all putative homologs ( Figure S1B ; 476-508 of human MRRP3), the identity of the only four amino acids strictly conserved is most striking: (three) aspartate(s) and histidine, the side chains of which are most commonly involved in active-site metal ion coordination of protein metallonucleases (Dupureur, 2008) . It is thus seductive to speculate that MRPP3 contains a novel metallonuclease domain and enables RNA hydrolysis via mechanisms basically identical to those proposed for RNA-based enzymes (Steitz and Steitz, 1993) . Whereas all three mtRNase P proteins appear to have some RNA-binding potential, their exact stoichiometry and interactions, their individual contribution to substrate recognition and specificity, and their precise role in hydrolysis/catalysis remain to be determined. Nonetheless, some observations made during their identification warrant extra mention here: (1) MRPP1 and MRPP2 constitute a stable subcomplex; (2) MRPP1 might be a limiting building block of the holoenzyme in vivo, as its overexpression alone was sufficient to increase mtRNase P activity; and (3) interaction of MRPP3 with the MRPP1/MRPP2 subcomplex is so weak that it is apparently broken by salt concentrations as low as 150 mM. The last observation casts doubt as to whether mtRNase P is at all a stable protein complex or rather the concerted action of two more dynamically interacting subunits on a common substrate. In any case, the loose connection of the holoenzyme finally turned out to be the true obstacle encountered during enzyme purification, explaining poor recovery and increase in specific activity. In fact it appears unlikely that a conventional purification-to-homogeneity approach could at all have been successful, and we believe that the PPOP approach is a more generally useful strategy for the identification of the components of fragile enzymatic activities. mtRNase P's Relation to Other RNase P Enzymes As exotic as the composition of human mtRNase P may appear, as ordinary are its enzymatic properties. Consistent with previous findings on the native mitochondrial enzyme (Rossmanith et al., 1995) , the recombinant enzyme is a precise, tRNA-specific endonuclease removing 5 0 extensions from pre-tRNAs, requiring Mg 2+ , and leaving the phosphate at the tRNA's 5 0 end. Thereby human mtRNase P is indistinguishable by any of the defining criteria (EC 3.1.26.5) from the RNA-based RNase P enzymes, which is not to imply, however, that the proteinaceous enzyme uses either a similar or a different cleavage mechanism than the ribozymes.
The identification of the components of human mtRNase P also confirms previous inferences drawn from the characterization of its native form about its relation to nRNase P and an RNase P activity related or identical to the nuclear enzyme, which was reported to be associated with mitochondria (Puranam and Attardi, 2001; Rossmanith and Potuschak, 2001; Rossmanith et al., 1995) . Evidently, mtRNase P, as molecularly and functionally defined by our work, does not share any components with the nuclear enzyme. Thus it seems theoretically possible that human mitochondria contain two RNase P enzymes, one of which related to the nuclear enzyme. We have previously discussed in detail why we consider such a scenario implausible and a functional association of nRNase P components with mitochondria not sufficiently supported by the available evidence (Rossmanith and Potuschak, 2001 ). Although the current work also cannot finally resolve this issue, two results of our study nevertheless deserve mention in this context: (1) (mt)pre-tRNA accumulation after RNAi silencing of MRPP genes excludes a full redundancy with a hypothetical alternative mtRNase P; (2) none of the 884 proteins identified in the five partially purified mtRNase P preparations is a component of nRNase P. Likewise, no nRNase P protein is currently listed in any of the comprehensive, experimentally derived mitochondrial proteome inventories (Pagliarini et al., 2008 and references therein; Prokisch and Ahting, 2007) . In contrast, the designation of the enzyme originally identified in 1995 and molecularly characterized in this work, as ''mitochondrial'' is warranted by (1) the subcellular distribution of its activity (Rossmanith et al., 1995) , (2) the predicted subcellular localization of its three subunits by subcellular sorting algorithms, (3) the reported subcellular localization of MRPP1 (RG9MTD1; Pagliarini et al., 2008) and MRPP2 (HSD17B10; Yang et al., 2005) and the mitochondrial localization of GFP-tagged MRPP3 (J.H., E.L., and W.R., unpublished data), (4) its specificity for (mt)pre-tRNAs (Rossmanith et al., 1995) , and (5) the increase in steady-state levels of (mt)pre-tRNAs after knockdown of any of its three components by RNAi.
The Evolution of Animal mtRNase P Knowing that RNase P is a pure protein enzyme in human mitochondria, it appears even more surprising now that an RNA world remnant has been kept in most principal genetic systems for such a seemingly straightforward reaction and has not been replaced more often by a protein enzyme during evolution, while most other putative enzymatic players of the former RNA world disappeared without a trace. But, why and when has the RNAbased enzyme, inherited from the a-proteobacterial ancestor and still kept in fungi, been displaced by its protein successor in animal mitochondria, and where else? Addressing this last issue first, plant chloroplast and trypanosomal mitochondrial RNase P are obvious candidates that might have found an independent solution for RNA-free tRNA processing during evolution (Gegenheimer, 1996; Salavati et al., 2001) . The presence of putative MRPP3 homologs in these organelles, however, suggests that at least some kind of relation to the animal mitochondrial enzyme might exist. Intriguingly, plant MRPP3 proteins are predicted to localize to chloroplasts as well as to mitochondria; and the composition of plant mitochondrial RNase P is completely unknown. Sequencing and analysis of the genome of the thermophilic bacterium Aquifex aeolicus revealed the lack of rnpA and rnpB, the bacterial genes encoding the protein and RNA component of bacterial RNase P (Swanson, 2001) , and an RNase P activity in A. aeolicus extracts was reported to be resistant to micrococcal nuclease (Marszalkowski et al., 2008) . However, like other bacterial genomes, the A. aeolicus genome contains no homologs to MRPP1 or MRPP3, suggesting yet an entirely different type of RNase P in this bacterium. The peculiar structure and evolution of animal mitochondrial genomes and their general lack of an RNase P RNA gene suggest that the switch from RNA to protein-based RNase P has not happened late in vertebrate evolution but rather early in the diversification of metazoans, if not at all at their root. The evolution of the three protein components appears basically consistent with such a hypothesis. However, sequence information is currently heavily biased toward vertebrate and insect genomes, and no comprehensive genomic information is available from more ancient metazoan taxa.
Yet, why of all genetic systems has RNA-based catalysis been abandoned in animal mitochondria? Possibly, the RNA world player failed to coevolve fast enough with the degenerating structures of animal mitochondrial tRNAs, leaving room for a patchwork assembly of three enzymes, including a tRNA methyltransferase as a putative tRNA specificity factor, to jump into the breach. Genome compaction could be another driving force, and the long leader and trailer sequences, which are mRNA or rRNA precursors, themselves indirectly relying on tRNA processing for their maturation too (Ojala et al., 1981) are also an unusual feature compared to nuclear encoded or bacterial pre-tRNAs. However, genome compaction and tRNA punctuation of mRNAs are also found in yeast mitochondria, the genomes of which have retained an RNase P RNA gene (Schä fer, 2005) . Presumably, only a thorough comparison of protein and RNA enzymes or the identification of further proteinaceous enzymes will show if what we have described herewith is just a further freak of nature found in the strange animal mitochondrial genetic system or reflects specific evolutionary constraints that forced animal mitochondria to abandon their RNA-based enzyme for a patchwork of three proteins.
EXPERIMENTAL PROCEDURES
Precursor tRNA Substrates, M1 RNA Pre-tRNA substrates were synthesized essentially as previously described (Rossmanith et al., 1995) . See Supplemental Experimental Procedures for details. M1 RNA was transcribed from pJA2 (kindly provided by Leif A. Kirsebom).
mtRNase P Activity Assay Pre-tRNA processing reactions were carried out essentially as previously described (Rossmanith et al., 1995) . For mtRNase P reconstitution, recombinant MRPP1, MRPP2, and MRPP3 were preincubated for 30 min at room temperature. See Supplemental Experimental Procedures for details.
Partial Purification of HeLa Cell mtRNase P Mitochondria were prepared and purified essentially as previously described (Rossmanith et al., 1995) . Cleared detergent lysates or sonicates were subjected to column chromatography using commercially available columns on an Ä KTAexplorer FPLC system (GE Healthcare) according to the columnsuppliers' instructions. Rate-zonal sedimentation in glycerol gradients was carried out as previously described (Rossmanith and Karwan, 1998a) . See Supplemental Experimental Procedures for details.
Protein Identification and Overlap Analysis mtRNase P peak-fractions of the partially purified preparations were concentrated by ultrafiltration and 15-40 mg total protein separated by SDS-PAGE. Entire gel lanes were cut into slices, digested in situ with trypsin, and analyzed by nanoflow liquid chromatography tandem mass spectrometry. The complete analysis (from gel to mass spectrometry) was performed using both an ion-trap and a quadrupole time-of-flight (QTOF) mass spectrometer. Proteins were identified by automated database searching against the human IPI database using Spectrum Mill (Agilent) and Mascot (Matrix Science) search engines. See Supplemental Experimental Procedures for details.
As the output formats of the two mass spectrometry platforms were not compatible, the data could not be integrated using commercially available mass spectrometry analysis software. Therefore, proteome comparison and compilation of the PPOP were based on the IPI accession numbers of the identified proteins and performed by Excel (Microsoft) spreadsheet analysis (see Tables S1-S9 for details).
Bioinformatic Protein Analysis
We used InterProScan for domain/motif analyses (Mulder et al., 2007) and Mitoprot and ChloroP for the prediction of mitochondrial and chloroplast targeting sequences, respectively (Claros and Vincens, 1996; Emanuelsson et al., 1999) .
Cloning and Overexpression of Putative mtRNase P Genes in 293 Cells
Complete coding sequences of candidate genes including their native initiation codon context were cloned by PCR (Table S11) in frame with a C-terminal myc-63 His or FLAG-tag. T-Rex-293 cells (Invitrogen) were transfected and stable cell lines selected; see Supplemental Experimental Procedures for details. For overexpression, cell lines were induced at 50% confluence with 0.5 mg/ml tetracycline and hyperconfluent cells harvested 4 days later.
Affinity Chromatography and Immunoprecipitation of Putative mtRNase P Proteins For immobilized metal affinity chromatography (IMAC) and immunoprecipitation, commercially available affinity gels and columns were used according to the supplier's instructions. See Supplemental Experimental Procedures for details.
Protein Elution/Renaturation from SDS-PAGs
Slices from unstained and unfixed SDS-PAGs were washed thrice with H 2 O and once with buffer ER (20 mM TrisCl [pH 7.4], 150 mM NaCl, 15% glycerol, 1 mM DTT, 0.1% proteinase inhibitor cocktail, 0.1% Tween 20), and proteins diffusion-eluted with buffer ER at 16 C overnight.
Cloning and Bacterial Expression of MRPP1, MRPP2, and MRPP3
The coding sequences of the putative mature mitochondrial peptides were cloned in frame with a 63 His-tag (Table S11 ); see Supplemental Experimental Procedures for details. Expression in E. coli BL21(DE3) was induced at an optical density (600 nm) of 0.8 by 1 mM IPTG and continued overnight at 16 C.
Affinity Chromatography of Recombinant MRPP1, MRPP2, and MRPP3 Washed bacteria were broken by sonication in buffer H (20 mM TrisCl [pH 7.4], 15% glycerol, 0.1 mM DTT, 0.1% proteinase inhibitor cocktail, 0.02% Tween 20) containing 150 mM NaCl and 30 mM imidazole, cleared as described for mitochondrial extracts (see Supplemental Experimental Procedures), and applied to a 1 ml HisTrap HP column (GE Healthcare) equilibrated and washed with the same buffer. After washing at 100 to 125 mM imidazole, recombinant proteins were eluted by a linear gradient to 500 mM imidazole.
Micrococcal Nuclease Treatment
Reconstituted mtRNase P was incubated with 30 units micrococcal nuclease per mg recombinant protein and 10 mM CaCl 2 for 30 min at 30 C. The digestion was stopped with 30 mM EGTA and mtRNase P activity assays carried out in the presence of 0.25 mg/ml poly(A).
